{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Standard+of+Care+Placebo&page=2", "query": { "intervention": "Standard of Care Placebo", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 989, "total_pages": 99, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Standard+of+Care+Placebo&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Standard+of+Care+Placebo&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-05T13:42:42.441Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05353257", "title": "A Study to Evaluate the Efficacy and Safety of Serplulimab in Combination With Chemotherapy and Concurrent Radiotherapy in Patients With Limited-Stage Small Cell Lung Cancer", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Limited-Stage Small Cell Lung Cancer" ], "interventions": [ { "name": "HLX10", "type": "DRUG" }, { "name": "carboplatin/cisplatin-etoposide", "type": "DRUG" }, { "name": "Thoracic radiotherapy", "type": "RADIATION" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Prophylactic Cranial Irradiation (PCI)", "type": "RADIATION" } ], "intervention_types": [ "DRUG", "RADIATION" ], "sponsor": "Shanghai Henlius Biotech", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 511, "start_date": "2022-05-17", "completion_date": "2028-05-30", "has_results": false, "last_update_posted_date": "2026-01-13", "last_synced_at": "2026-10-05T13:42:42.441Z", "location_count": 31, "location_summary": "Arcadia, California • Los Alamitos, California • Los Angeles, California + 26 more", "locations": [ { "city": "Arcadia", "state": "California" }, { "city": "Los Alamitos", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Redlands", "state": "California" }, { "city": "Santa Rosa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05353257" }, { "nct_id": "NCT04724720", "title": "Famotidine vs Placebo for the Treatment of Non-Hospitalized Adults With COVID-19", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Covid-19" ], "interventions": [ { "name": "Famotidine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Northwell Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 56, "start_date": "2021-01-19", "completion_date": "2022-01-25", "has_results": true, "last_update_posted_date": "2026-06-15", "last_synced_at": "2026-10-05T13:42:42.441Z", "location_count": 1, "location_summary": "Lake Success, New York", "locations": [ { "city": "Lake Success", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04724720" }, { "nct_id": "NCT06069154", "title": "Ultrasound-Guided Percutaneous Cryoneurolysis to Treat Pain Following Thoracic Trauma", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Rib Fracture", "Rib Fracture Multiple" ], "interventions": [ { "name": "Cryoneurolysis", "type": "DEVICE" }, { "name": "Local anesthetic peripheral nerve block", "type": "PROCEDURE" }, { "name": "Sham Cryoneurolysis", "type": "DEVICE" }, { "name": "Sham peripheral nerve block", "type": "PROCEDURE" } ], "intervention_types": [ "DEVICE", "PROCEDURE" ], "sponsor": "University of California, San Diego", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 120, "start_date": "2023-10-30", "completion_date": "2028-12", "has_results": false, "last_update_posted_date": "2026-08-24", "last_synced_at": "2026-10-05T13:42:42.441Z", "location_count": 5, "location_summary": "La Jolla, California • Bethesda, Maryland • Boston, Massachusetts + 1 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Bethesda", "state": "Maryland" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06069154" }, { "nct_id": "NCT01594762", "title": "Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diabetic Foot Infection" ], "interventions": [ { "name": "Topical pexiganan cream 0.8%", "type": "DRUG" }, { "name": "Topical placebo cream", "type": "DRUG" }, { "name": "Standard wound care", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Dipexium Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 200, "start_date": "2014-06", "completion_date": "2016-07", "has_results": true, "last_update_posted_date": "2017-06-14", "last_synced_at": "2026-10-05T13:42:42.441Z", "location_count": 39, "location_summary": "Phoenix, Arizona • Tucson, Arizona • Jonesboro, Arkansas + 36 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Castro Valley", "state": "California" }, { "city": "Davis", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01594762" }, { "nct_id": "NCT03298061", "title": "Long-term Access Program (LAP) of Mepolizumab for Subjects Who Participated in Study MEA115921", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Churg-Strauss Syndrome", "Eosinophilic Granulomatosis With Polyangiitis" ], "interventions": [ { "name": "Mepolizumab", "type": "DRUG" }, { "name": "Prednisolone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2015-04-14", "completion_date": "2023-02-16", "has_results": true, "last_update_posted_date": "2024-03-12", "last_synced_at": "2026-10-05T13:42:42.441Z", "location_count": 14, "location_summary": "Denver, Colorado • Bethesda, Maryland • Boston, Massachusetts + 10 more", "locations": [ { "city": "Denver", "state": "Colorado" }, { "city": "Bethesda", "state": "Maryland" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT03298061" }, { "nct_id": "NCT05891496", "title": "A Research Study Looking at the Effect of Semaglutide on the Immune System and Other Biological Processes in People With Alzheimer's Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Alzheimers Disease" ], "interventions": [ { "name": "Semaglutide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novo Nordisk A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "55 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "55 Years to 75 Years" }, "enrollment_count": 23, "start_date": "2023-06-20", "completion_date": "2025-09-08", "has_results": true, "last_update_posted_date": "2026-08-18", "last_synced_at": "2026-10-05T13:42:42.441Z", "location_count": 2, "location_summary": "Sun City, Arizona • Delray Beach, Florida", "locations": [ { "city": "Sun City", "state": "Arizona" }, { "city": "Delray Beach", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05891496" }, { "nct_id": "NCT06979804", "title": "A Comparison of Outcomes After Anterior Cruciate Ligament (ACL) or Anterior Cruciate Ligament and Meniscus (ACL+Meniscus) Surgery Using Semiconductor Fabric Products", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "ACL Reconstruction", "Meniscus Tears", "Anterior Cruciate Ligament Rupture" ], "interventions": [ { "name": "Semiconducting fabric sleeves", "type": "DEVICE" }, { "name": "Non-semiconducting fabric sleeves", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Illinois Center for Orthopaedic Research and Education", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "16 Years to 65 Years" }, "enrollment_count": 135, "start_date": "2024-09-11", "completion_date": "2026-10-01", "has_results": false, "last_update_posted_date": "2025-05-22", "last_synced_at": "2026-10-05T13:42:42.441Z", "location_count": 1, "location_summary": "Westmont, Illinois", "locations": [ { "city": "Westmont", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT06979804" }, { "nct_id": "NCT07241585", "title": "Vitamin D Effects on Immune Microenvironment of Nonmelanoma Skin Cancer After Photodynamic Therapy (PDT)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Nonmelanoma Skin Cancer", "Basal Cell Carcinoma", "Squamous Cell Carcinoma" ], "interventions": [ { "name": "Vitamin D (VitD)", "type": "DIETARY_SUPPLEMENT" }, { "name": "Placebo", "type": "OTHER" }, { "name": "Photodynamic therapy (PDT)", "type": "OTHER" }, { "name": "Mohs surgery or electrodessication & curettage (ED&C) (standard of care)", "type": "PROCEDURE" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "OTHER", "PROCEDURE" ], "sponsor": "Case Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 54, "start_date": "2026-02-25", "completion_date": "2027-08", "has_results": false, "last_update_posted_date": "2026-08-18", "last_synced_at": "2026-10-05T13:42:42.441Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT07241585" }, { "nct_id": "NCT04718389", "title": "A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "GSK3511294 (Depemokimab)", "type": "BIOLOGICAL" }, { "name": "Mepolizumab", "type": "BIOLOGICAL" }, { "name": "Benralizumab", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" }, { "name": "Standard of care (SoC)", "type": "DRUG" }, { "name": "Pre-filled Syringes (PFS)", "type": "DEVICE" } ], "intervention_types": [ "BIOLOGICAL", "DRUG", "DEVICE" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 1717, "start_date": "2021-01-26", "completion_date": "2025-09-14", "has_results": true, "last_update_posted_date": "2026-05-18", "last_synced_at": "2026-10-05T13:42:42.441Z", "location_count": 119, "location_summary": "Birmingham, Alabama • Scottsboro, Alabama • Litchfield Park, Arizona + 94 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Scottsboro", "state": "Alabama" }, { "city": "Litchfield Park", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT04718389" }, { "nct_id": "NCT00890526", "title": "Intervention for Reduced Sound Tolerance", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Hyperacusis" ], "interventions": [ { "name": "Sound Therapy (Tinnitus Retraining Therapy)", "type": "OTHER" }, { "name": "Counseling (Tinnitus Retraining Therapy)", "type": "OTHER" }, { "name": "No Counseling", "type": "OTHER" }, { "name": "Placebo Sound Therapy", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Alabama, Tuscaloosa", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 36, "start_date": "2002-07", "completion_date": "2010-09", "has_results": false, "last_update_posted_date": "2012-06-21", "last_synced_at": "2026-10-05T13:42:42.441Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00890526" } ] }